Senate Anti-Meth Caucus
This article was originally published in The Tan Sheet
Executive Summary
Sens. Dianne Feinstein (D-Calif.) and Jim Talent (R-Mo.) are co-chairs of the Senate's new Anti-Meth Caucus, according to an Oct. 7 announcement. The caucus will work with local law enforcement "to push legislation that helps them stay ahead of the meth cooks," Talent says, noting that treatment and prevention will also be targets. Fellow caucus co-chairs are Sens. Joe Biden (D-Del.), Chuck Grassley (R-Iowa.), Kent Conrad (D- N.D.) and Conrad Burns (R-Mont.). Sens. Talent and Feinstein co-sponsored a federal bill that would place pseudoephedrine, a meth precursor, behind pharmacy counters. The Combat Meth Act awaits the approval of a House and Senate Conference Committee, the last step before being signed into law (1"The Tan Sheet" Sept. 12, 2005, p. 5 and 2"The Tan Sheet" Sept. 19, 2005, In Brief)...
You may also be interested in...
Meth Act Passes In Senate Commerce, Justice & Science Appropriations Bill
Unanimous Senate support of the Combat Meth Act, coupled with the bill's attachment to a spending bill, improves the odds for more unified national pseudoephedrine restrictions
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.